Ara

Toplam kayıt 12, listelenen: 1-10

Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry

Özlek, Bülent; Ozlek, Eda; Tekinalp, Mehmet; Kahraman, Serkan; Agus, Hicaz Zencirkiran; Başaran, Özcan; Biteker, Murat (Turkish Soc Cardiology, 2020)

Objective: The aim of this study was to assess the clinical characteristics of patients with heart failure and preserved ejection fraction (HFpEF) and atrial fibrillation (AF) and compare them with those of HFpEF patients ...

Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?

Kalemci, Serdar; Altun, İbrahim; Akın, Fatih; Biteker, Murat (Elsevier Ireland Ltd, 2015)

[No abstract available]

Metoprolol vs ivabradine in patients with mitral stenosis

Ergün, Gökhan; Doğan, Volkan; Başaran, Özcan; Biteker, Murat (Elsevier Ireland Ltd, 2016)

[No abstract available]

Obesity and atrial fibrillation

Ergün, Gökhan; Başaran, Özcan; Doğan, Volkan; Doğan, Marwa Mouline; Biteker, Murat (Elsevier Ireland Ltd, 2016)

Letter to Editor

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)

Başaran, Özcan; Beton, Osman; Doğan, Volkan; Tekinalp, Mehmet; Aykan, Ahmet Çağrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Turkish Soc Cardiology, 2016)

Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...

Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study

Başaran, Özcan; Doğan, Volkan; Beton, Osman; Tekinalp, Mehmet; Aykan, Ahmet Çagrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Springer, 2017)

The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ...

Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study

Başaran, Özcan; Doğan, Volkan; Biteker, Murat; Karadeniz, Fatma Özpamuk; Tekkesin, Ahmet İlker; Çakıllı, Yasin; Kırma, Cevat (Elsevier Science Bv, 2017)

Objective: No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...

Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study

Biteker, Murat; Başaran, Özcan; Doğan, Volkan; Altun, İbrahim; Karadeniz, Fatma Özpamuk; Tekkesin, Ahmet İlker; Bozyel, Serdar (Wiley, 2017)

ObjectivesTo compare the clinical characteristics of and use of oral anticoagulant (OAC) therapy in individuals aged 80 and older with atrial fibrillation (AF) with those of individuals younger than 80 with AF in clinical ...

Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study

Biteker, Murat; Başaran, Özcan; Doğan, Volkan; Beton, O.; Tekinalp, M.; Aykan, Ahmet Çağrı; Kırma, C. (Wiley, 2016)

What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...

Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies

Başaran, Özcan; Doğan, Volkan; Sancar, Kadriye Memic; Altun, İbrahim; Mert, Kadir Ugur; Mert, Gurbet Ozge; Biteker, Murat (Turkish Soc Cardiology, 2016)

Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ...